Merck's Cholesterol Trial Win Puzzles as FDA Filing Uncertain

(Bloomberg) -- An experimental cholesterol drug developed by Merck & Co. succeeded in reducing heart risks in a late-stage trial, a surprise win for a class of treatments that has failed numerous t...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.